Peer insightsfrom a CLEVIPREX® (clevidipine) user

Dr. Horowitz speaks about CLEVIPREX
Renowned anesthesiologist Dr. Horowitz discusses CLEVIPREX clinical trial results and dosing in a series of informative videos for healthcare professionals.
Medical Director, Department of Anesthesiology, Delray Medical Center

CLEVIPREX Clinical Trials
Dr. Horowitz discusses efficacy and safety outcomes from pivotal trials in a variety of patient types and settings, including perioperative hypertension and acute severe hypertension.

Dosing CLEVIPREX
Get an overview of how to properly administer and dose CLEVIPREX presented by Dr. Horowitz.
Connect with a KOL
Individualized, titratable administration1
CLEVIPREX offers low-volume, non–weight-based dosing that is independent of renal or hepatic function.

Proven efficacy in clinical studies1-5
CLEVIPREX provided blood pressure reduction in a range of patients and various clinical settings.
Onset within minutes1
CLEVIPREX has a titratable, fast onset of action and short half-life.